Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term high-dose. Found 7 abstracts

Motzer RJ, Agarwal N, Beard C, Bhayani S, Bolger GB, Buyyounouski MK, Carducci MA, Chang SS, Choueiri TK, Gupta S, Hancock SL, Hudes GR, Jonasch E, Kuzel TM, Lau C, Levine EG, Lin DW, Margolin KA, Michaelson MD, Olencki T, Pili R, Ratliff TW, Redman BG, Robertson CN, Ryan CJ, Sheinfeld J, Wang J, Wilder RB. Testicular Cancer Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2012 Apr;10(4):502-35.   PMCID: not NIH funded
Brem SS, Bierman PJ, Brem H, Butowski N, Chamberlain MC, Chiocca EA, DeAngelis LM, Fenstermaker RA, Friedman A, Gilbert MR, Hesser D, Junck L, Linette GP, Loeffler JS, Maor MH, Michael M, Moots PL, Morrison T, Mrugala M, Nabors LB, Newton HB, Portnow J, Raizer JJ, Recht L, Shrieve DC, Sills AK, Vrionis FD, Wen PY. Central Nervous System Cancers. Journal of the National Comprehensive Cancer Network. 2011 Apr;9(4):352-400.   PMCID: not NIH funded
Biermann JS, Adkins DR, Benjamin RS, Brigman B, Chow W, Conrad EU, Frassica DA, Frassica FJ, George S, Hande KR, Hornicek FJ, Letson GD, Mayerson J, McGarry SV, McGrath B, Morris CD, O'Donnell RJ, Randall RL, Santana VM, Satcher RL, Siegel HJ, Somaiah N, Yasko AW. Bone Cancer. Journal of the National Comprehensive Cancer Network. 2010 Jun;8(6):688-712.   PMCID: not NIH funded
Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C. Colon Cancer. Journal of the National Comprehensive Cancer Network. 2009 Sep;7(8):778-831.   PMCID: no NIH - Practice Guideline
Mock V, Atkinson A, Barsevick A, Cella D, Cimprich B, Cleeland C, Donnelly J, Eisenberger MA, Escalante C, Hinds P, Jacobsen PB, Kaldor P, Knight SJ, Peterman A, Piper BF, Rugo H, Sabbatini P, Stahl C. NCCN Practice Guidelines for cancer-related fatigue. Oncology-New York. 2000 Nov;14(11A):151-61.
Visonneau S, Cesano A, Porter DL, Luger SL, Schuchter L, Kamoun M, Torosian MH, Duffy K, Sickles C, Stadtmauer EA, Santoli D. Phase I trial of TALL-104 cells in patients with refractory metastatic breast cancer. Clinical Cancer Research. 2000 May;6(5):1744-54.
Schilder RJ, Lacreta FP, Perez RP, Johnson SW, Brennan JM, Rogatko A, Nash S, McAleer C, Hamilton TC, Roby D, Young RC, Ozols RF, Odwyer PJ. Phase-I and Pharmacokinetic Study of Ormaplatin (Tetraplatin, Nsc-363812) Administered on a Day-1 and Day-8 Schedule. Cancer Research. 1994 Feb;54(3):709-17.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term high-dose

high-dose chemotherapy NCCN Clinical Practice Guidelines NCCN Guidelines surgery cisplatin therapy irinotecan positron-emission-tomography high-grade osteosarcoma term-follow-up germ cell tumors neoplasm staging impaired renal-function alpha-fetoprotein neuropathy soluble phase-ii trial spinal-cord compression quality-of-life bone cancer radiotherapy plus concomitant hypertonic saline stem-cell rescue nonseminoma cisplatin-based chemotherapy metastatic colorectal-cancer lymph-node dissection cytotoxicity testicular cancer stage-i seminoma neoplasm recurrence brain metastases brain radiation-therapy oxaliplatin germ-cell tumors cell lung-carcinoma colonic neoplasms adjuvant chemotherapy angiogenesis platinum(ii) indiana-university experience european-osteosarcoma-intergroup medulloblastoma chorionic gonadotropin 2011 ung p-j natl cancer i-v103-p194 interleukin-2 gemcitabine average-risk medulloblastoma primitive neuroectodermal tumors medical-research-council dexamethasone long-term survival immunodeficient scid mice bone-marrow transplantation oxaliplatin-based ewings-sarcoma family seminoma controlled-trial 9:352-400) healthy-individuals metastasis Ewing's sarcoma growth-factor receptor breast-cancer fluorouracil plus leucovorin carcinoma cell-lines human refractory lactate dehydrogenase pediatric-oncology-group nephrotoxicity 1993 bruin mjfm-british journal of urology-v71-p336 colorectal gamma-knife surgery lymph-node micrometastases stem-cell transplantation community oncology spinal tumors 2006 giorgi u-eur urol-v50-p1038 2002 oo r-can j urol-v9-p1479 temozolomide recurrent malignant glioma bevacizumab unresectable liver metastases carcinoma solid tumors sloan-kettering experience line tall-104 brain tumor astrocytoma 2010 ung pw-j clin oncol-v28 phase-iii trial lung-cancer intervention salvage chemotherapy refractory solid tumors anaplastic astrocytoma 5-fluorouracil randomized osteosarcomas carboplatin activated killer-cells PTEN (JNCCN 2011 adenocarcinoma radiation therapy recombinant adjuvant sarcoma 2002 ung p-can j urol-v9-p1637 chondrosarcomas leucovorin interleukin-2 receptors glioblastoma aerobic exercise
Last updated on Wednesday, February 05, 2020